Search
Now showing items 1-10 of 50
Physical activity in a pandemic: A new treatment target for psychological therapy.
(2020-06)
The COVID-19 pandemic and its management are placing significant new strains onpeople’s well-being, particularly those with pre-existing mental health conditions. Physicalactivity has been shown to improve mental as well ...
What does COVID mean for UK mental health care?
(2020-06)
The coronavirus disease (COVID) pandemic is the biggest disaster United Kingdom has seen for many decades. Not since World War II has there been such risk, displacement and change affecting the whole community. This is the ...
COVID-19, mental health and ethnic minorities
(2020-07)
There is little formal guidance
for the busy clinician in balancing
different risks for individual mental health
patients and treating appropriately. To fill this gap, we propose three core
actions that may help:
1. ...
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
(2020-07)
Background
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be curtailed by vaccination. We assessed the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine ...
The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: a living systematic review [version 1; peer review: 1 approved]
(2020-09)
Background: The COVID-19 pandemic has caused morbidity and
mortality, as well as, widespread disruption to people’s lives and
livelihoods around the world. Given the health and economic threats
posed by the pandemic to ...
Reporting on suicidal behaviour and COVID-19—need for caution
(2020-11)
News reporting on suicidal behaviour
can have a considerable influence
on suicide and self-harm in the
general population.1
This issue is
particularly relevant during the
COVID-19 pandemic. With a rising
number of ...
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
(2020-12)
Background
Older adults (aged ≥70 years) are at increased risk of severe disease and death if they develop COVID-19 and are therefore a priority for immunisation should an efficacious vaccine be developed. Immunogenicity ...
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
(2020-12)
More than 190 vaccines are currently in development to prevent infection by the novel severe acute respiratory syndrome coronavirus 2. Animal studies suggest that while neutralizing antibodies against the viral spike protein ...
Effects of the COVID-19 pandemic on self-harm
(2020-12)
There has been extensive discussion, some of it data-based1 but much of it speculative, on the effect of the COVID-19 pandemic on suicide. Since death by suicide requires thorough investigation by professionals, such as ...
Cognitive therapy for moral injury in post-traumatic stress disorder
(2021-01)
Moral injury is the profound psychological distress which can arise following participating in, or
witnessing, events which transgress an individual’s morals and include harming, betraying, or
failure to help others, or ...